BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated

Around 9,000 New Zealanders die of cancer every year.[2] New campaign launched today encourages people to get unusual and persistent symptoms chec...

September 20, 2021 | News

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

The multi-ministerial project is overseen by the Ministry of Health and Welfare, Ministry of Trade and Industry, Ministry of Science and ICT, and Korea Dis...

September 20, 2021 | News

India Ministry of Health & FW Approves Exablate Neuro Focused Ultrasound Platform

The Exablate 4000 (Exablate Neuro) platform uses MR-guided focused ultrasound to precisely ablate a small target deep within the brain without incisio...

September 20, 2021 | News

Everest to support future development and commercialization globally for the treatment of renal diseases

Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...

September 17, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

September 15, 2021 | News

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

September 14, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

September 13, 2021 | News

HaemaLogiX raises $10 million to advance multiple myeloma treatments

HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor w...

September 09, 2021 | News

WHO South-East Asia countries resolve to reorient and strengthen health system

“Strong health systems that are primary health care-oriented, and which leave no one behind, create populations that are healthier, more productive a...

September 08, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

September 07, 2021 | News

TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund

TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings ...

September 06, 2021 | News

WHO SEA Region to discuss pandemic, rebuilding essential health services for UHC

The Seventy Fourth Regional Committee Session of WHO South-East Asia, the annual governing body meeting of WHO in the Region, is being hosted by Nepal from...

September 03, 2021 | News

Abbott to treat minimally invasive patients with aortic valve disease

The catheter aortic valve implantation (TAVI) procedure treats people with severe and symptomatic aortic snoosis whose surgical risk is considered high or ...

September 03, 2021 | News

Stay Connected